Start-up Capital, Seed Capital, Expansion - Development Capital, Early-Stage
Industrial Sectors
Medical - Life Sciences - Health Related, Energy, Biotechnology
Geographical Focus
Continental Europe
Type of Financing
Equity Financing
Company Profile
Short company profile
Aravis is an independent Swiss based venture capital firm. Our funds invest in early stage companies in the Biotech and renewable Energy infrastructure sectors, taking active roles from start up to public. With CHF 170M under management Aravis is one of the largest Swiss Venture investor. Our investors are primarily institutional, family offices as well as corporate. The investment partners are dedicated to their respective sectors bringing their strong experience and solid network for the benefits of portfolio companies. We prefer to take lead investor roles and syndicate financings internationally. Aravis Energy I LP was the first ever approved Swiss Limited partnership by the FINMA, the Swiss financial market supervisory authority.
Number of employees in Switzerland
6
Capital under Management
CHF 170m
Fund Names
Aravis Venture I, LP; Aravis Biotech II, LP; Aravis Energy I, LP
Number of Portfolio Companies
24
Examples of Portfolio Companies
Evolva, Telormedix
Year of Establishment
2001
Size of Investment
CHF 7-10m
Funds available to invest
yes
Minimum investment considered
CHF 1m
Maximum investment considered
CHF 10m
Average equity stake
15-20 %
Timescale for investments
5 years
Source of funds
Fund of Funds, Institutionnal, Familly Offices
Preferred exit route
Trade Sale
Member Zone
Our Member Zone provides research publications, downloads regarding past events and past newsletters.
